Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOBUPIVACAINE for Spinal anaesthesia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 11 adverse event reports in the FDA FAERS database where LEVOBUPIVACAINE was used for Spinal anaesthesia.

Most Reported Side Effects for LEVOBUPIVACAINE

Side Effect Reports % Deaths Hosp.
Hypotension 38 9.6% 1 17
Anaphylactic reaction 32 8.1% 0 9
Cardiac arrest 26 6.6% 6 11
Foetal exposure during pregnancy 24 6.1% 0 3
Maternal exposure during pregnancy 21 5.3% 0 12
Drug ineffective 20 5.1% 0 11
Premature baby 20 5.1% 0 0
Bradycardia 19 4.8% 0 5
Exposure during pregnancy 19 4.8% 1 7
Acute generalised exanthematous pustulosis 18 4.6% 0 7
Nausea 18 4.6% 0 14
Horner's syndrome 17 4.3% 0 6
Erythema 15 3.8% 0 12
Low birth weight baby 14 3.5% 0 0
Mydriasis 14 3.5% 0 13

Other Indications for LEVOBUPIVACAINE

Product used for unknown indication (61) Epidural anaesthesia (44) Anaesthesia (38) Nerve block (35) Local anaesthesia (27) Analgesic therapy (26) Epidural analgesia (24) Postoperative analgesia (23) Foetal exposure during pregnancy (12) General anaesthesia (11)

Other Drugs Used for Spinal anaesthesia

BUPIVACAINE (2,033) MORPHINE (377) FENTANYL (309) SUFENTANIL (132) LIDOCAINE (107) EPINEPHRINE (41) TRANEXAMIC ACID (39) ROPIVACAINE (38) CLONIDINE (30) FENTANYL\FENTANYL (25)

Related Pages

LEVOBUPIVACAINE Full Profile All Spinal anaesthesia Drugs LEVOBUPIVACAINE Demographics LEVOBUPIVACAINE Timeline